List of Tables
Table 1. Global Psychostimulants Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Psychostimulants Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Psychostimulants Market Competitive Situation by Manufacturers in 2024
Table 4. Global Psychostimulants Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Psychostimulants Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Psychostimulants Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Psychostimulants Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Psychostimulants Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Psychostimulants, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Psychostimulants, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Psychostimulants, Product Type & Application
Table 12. Global Key Manufacturers of Psychostimulants, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Psychostimulants by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psychostimulants as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Psychostimulants Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Psychostimulants Sales by Region (2020-2025) & (K Units)
Table 18. Global Psychostimulants Sales Market Share by Region (2020-2025)
Table 19. Global Psychostimulants Sales by Region (2026-2031) & (K Units)
Table 20. Global Psychostimulants Sales Market Share by Region (2026-2031)
Table 21. Global Psychostimulants Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Psychostimulants Revenue Market Share by Region (2020-2025)
Table 23. Global Psychostimulants Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Psychostimulants Revenue Market Share by Region (2026-2031)
Table 25. North America Psychostimulants Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Psychostimulants Sales by Country (2020-2025) & (K Units)
Table 27. North America Psychostimulants Sales by Country (2026-2031) & (K Units)
Table 28. North America Psychostimulants Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Psychostimulants Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Psychostimulants Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Psychostimulants Sales by Country (2020-2025) & (K Units)
Table 32. Europe Psychostimulants Sales by Country (2026-2031) & (K Units)
Table 33. Europe Psychostimulants Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Psychostimulants Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Psychostimulants Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Psychostimulants Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Psychostimulants Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Psychostimulants Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Psychostimulants Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Psychostimulants Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Psychostimulants Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Psychostimulants Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Psychostimulants Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Psychostimulants Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Psychostimulants Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Psychostimulants Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Psychostimulants Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Psychostimulants Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Psychostimulants Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Psychostimulants Sales (K Units) by Type (2020-2025)
Table 51. Global Psychostimulants Sales (K Units) by Type (2026-2031)
Table 52. Global Psychostimulants Sales Market Share by Type (2020-2025)
Table 53. Global Psychostimulants Sales Market Share by Type (2026-2031)
Table 54. Global Psychostimulants Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Psychostimulants Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Psychostimulants Revenue Market Share by Type (2020-2025)
Table 57. Global Psychostimulants Revenue Market Share by Type (2026-2031)
Table 58. Global Psychostimulants Price (US$/Unit) by Type (2020-2025)
Table 59. Global Psychostimulants Price (US$/Unit) by Type (2026-2031)
Table 60. Global Psychostimulants Sales (K Units) by Application (2020-2025)
Table 61. Global Psychostimulants Sales (K Units) by Application (2026-2031)
Table 62. Global Psychostimulants Sales Market Share by Application (2020-2025)
Table 63. Global Psychostimulants Sales Market Share by Application (2026-2031)
Table 64. Global Psychostimulants Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Psychostimulants Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Psychostimulants Revenue Market Share by Application (2020-2025)
Table 67. Global Psychostimulants Revenue Market Share by Application (2026-2031)
Table 68. Global Psychostimulants Price (US$/Unit) by Application (2020-2025)
Table 69. Global Psychostimulants Price (US$/Unit) by Application (2026-2031)
Table 70. Alkermes Company Information
Table 71. Alkermes Description and Business Overview
Table 72. Alkermes Psychostimulants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Alkermes Psychostimulants Product
Table 74. Alkermes Recent Developments/Updates
Table 75. Allergan Company Information
Table 76. Allergan Description and Business Overview
Table 77. Allergan Psychostimulants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Allergan Psychostimulants Product
Table 79. Allergan Recent Developments/Updates
Table 80. Bristol-Myers Squibb Company Information
Table 81. Bristol-Myers Squibb Description and Business Overview
Table 82. Bristol-Myers Squibb Psychostimulants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Bristol-Myers Squibb Psychostimulants Product
Table 84. Bristol-Myers Squibb Recent Developments/Updates
Table 85. Eli Lilly and Company Company Information
Table 86. Eli Lilly and Company Description and Business Overview
Table 87. Eli Lilly and Company Psychostimulants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Eli Lilly and Company Psychostimulants Product
Table 89. Eli Lilly and Company Recent Developments/Updates
Table 90. GlaxoSmithKline Company Information
Table 91. GlaxoSmithKline Description and Business Overview
Table 92. GlaxoSmithKline Psychostimulants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. GlaxoSmithKline Psychostimulants Product
Table 94. GlaxoSmithKline Recent Developments/Updates
Table 95. Lundbeck Company Information
Table 96. Lundbeck Description and Business Overview
Table 97. Lundbeck Psychostimulants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Lundbeck Psychostimulants Product
Table 99. Lundbeck Recent Developments/Updates
Table 100. Merck Company Information
Table 101. Merck Description and Business Overview
Table 102. Merck Psychostimulants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Merck Psychostimulants Product
Table 104. Merck Recent Developments/Updates
Table 105. Pfizer Company Information
Table 106. Pfizer Description and Business Overview
Table 107. Pfizer Psychostimulants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Pfizer Psychostimulants Product
Table 109. Pfizer Recent Developments/Updates
Table 110. Teva Pharmaceutical Industries Company Information
Table 111. Teva Pharmaceutical Industries Description and Business Overview
Table 112. Teva Pharmaceutical Industries Psychostimulants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Teva Pharmaceutical Industries Psychostimulants Product
Table 114. Teva Pharmaceutical Industries Recent Developments/Updates
Table 115. Takeda Pharmaceutical Company Information
Table 116. Takeda Pharmaceutical Description and Business Overview
Table 117. Takeda Pharmaceutical Psychostimulants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Takeda Pharmaceutical Psychostimulants Product
Table 119. Takeda Pharmaceutical Recent Developments/Updates
Table 120. Johnson and Johnson Company Information
Table 121. Johnson and Johnson Description and Business Overview
Table 122. Johnson and Johnson Psychostimulants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Johnson and Johnson Psychostimulants Product
Table 124. Johnson and Johnson Recent Developments/Updates
Table 125. Sanofi Company Information
Table 126. Sanofi Description and Business Overview
Table 127. Sanofi Psychostimulants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Sanofi Psychostimulants Product
Table 129. Sanofi Recent Developments/Updates
Table 130. Astrazeneca Company Information
Table 131. Astrazeneca Description and Business Overview
Table 132. Astrazeneca Psychostimulants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Astrazeneca Psychostimulants Product
Table 134. Astrazeneca Recent Developments/Updates
Table 135. Bayer HealthCare Pharmaceuticals Company Information
Table 136. Bayer HealthCare Pharmaceuticals Description and Business Overview
Table 137. Bayer HealthCare Pharmaceuticals Psychostimulants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Bayer HealthCare Pharmaceuticals Psychostimulants Product
Table 139. Bayer HealthCare Pharmaceuticals Recent Developments/Updates
Table 140. Boehringer Ingelheim GmbH Company Information
Table 141. Boehringer Ingelheim GmbH Description and Business Overview
Table 142. Boehringer Ingelheim GmbH Psychostimulants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Boehringer Ingelheim GmbH Psychostimulants Product
Table 144. Boehringer Ingelheim GmbH Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Psychostimulants Distributors List
Table 148. Psychostimulants Customers List
Table 149. Psychostimulants Market Trends
Table 150. Psychostimulants Market Drivers
Table 151. Psychostimulants Market Challenges
Table 152. Psychostimulants Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Psychostimulants
Figure 2. Global Psychostimulants Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Psychostimulants Market Share by Type: 2024 & 2031
Figure 4. Non-prescription Drugs Product Picture
Figure 5. Prescription Product Picture
Figure 6. Global Psychostimulants Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Psychostimulants Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Psychostimulants Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Psychostimulants Market Size (2020-2031) & (US$ Million)
Figure 13. Global Psychostimulants Sales (2020-2031) & (K Units)
Figure 14. Global Psychostimulants Average Price (US$/Unit) & (2020-2031)
Figure 15. Psychostimulants Report Years Considered
Figure 16. Psychostimulants Sales Share by Manufacturers in 2024
Figure 17. Global Psychostimulants Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Psychostimulants Players: Market Share by Revenue in Psychostimulants in 2024
Figure 19. Psychostimulants Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Psychostimulants Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Psychostimulants Sales Market Share by Country (2020-2031)
Figure 22. North America Psychostimulants Revenue Market Share by Country (2020-2031)
Figure 23. United States Psychostimulants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Psychostimulants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Psychostimulants Sales Market Share by Country (2020-2031)
Figure 26. Europe Psychostimulants Revenue Market Share by Country (2020-2031)
Figure 27. Germany Psychostimulants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Psychostimulants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Psychostimulants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Psychostimulants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Psychostimulants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Psychostimulants Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Psychostimulants Revenue Market Share by Region (2020-2031)
Figure 34. China Psychostimulants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Psychostimulants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Psychostimulants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Psychostimulants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Psychostimulants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Psychostimulants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Psychostimulants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Psychostimulants Sales Market Share by Country (2020-2031)
Figure 42. Latin America Psychostimulants Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Psychostimulants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Psychostimulants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Psychostimulants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Psychostimulants Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Psychostimulants Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Psychostimulants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Psychostimulants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Psychostimulants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Psychostimulants by Type (2020-2031)
Figure 52. Global Revenue Market Share of Psychostimulants by Type (2020-2031)
Figure 53. Global Psychostimulants Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Psychostimulants by Application (2020-2031)
Figure 55. Global Revenue Market Share of Psychostimulants by Application (2020-2031)
Figure 56. Global Psychostimulants Price (US$/Unit) by Application (2020-2031)
Figure 57. Psychostimulants Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
